Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697810 | Clinical Oncology | 2017 | 11 Pages |
Abstract
Neoadjuvant treatment offers a number of benefits for patients with early breast cancer, and is an important option for consideration by multidisciplinary teams. Despite literature showing its efficacy, the use of neoadjuvant therapy varies widely. Here we discuss the clinical evidence supporting the use of neoadjuvant therapy in early stage breast cancer, including patient selection, monitoring response, surgery and radiotherapy considerations, with the aim of assisting multidisciplinary teams to determine patient suitability for neoadjuvant treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
H. Cain, I.R. Macpherson, M. Beresford, S.E. Pinder, J. Pong, J.M. Dixon,